Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa von Buster, Erik H.C.J, Hansen, Bettina E, Lau, George K.K, Piratvisuth, Teerha, Zeuzem, Stefan, Steyerberg, Ewout W, Janssen, Harry L.A

Volltext

Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B von Sonneveld, Milan J, Wong, Vincent W.–S, Woltman, Andrea M, Wong, Grace L.H, Cakaloglu, Yilmaz, Zeuzem, Stefan, Buster, Erik H.C.J, Uitterlinden, Andre G, Hansen, Bettina E, Chan, Henry L.Y, Janssen, Harry L.A

Volltext

Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b von Buster, Erik H.C.J, Flink, Hajo J, Cakaloglu, Yilmaz, Simon, Krzysztof, Trojan, Jörg, Tabak, Fehmi, So, Thomas M.K, Feinman, S. Victor, Mach, Tomasz, Akarca, Ulus S, Schutten, Martin, Tielemans, Wanda, van Vuuren, Anneke J, Hansen, Bettina E, Janssen, Harry L.A

Volltext

Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues von Buster, Erik H.C.J., MD, Schalm, Solko W., MD, PhD, Janssen, Harry L.A., MD, PhD

Volltext

Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment von Hansen, Bettina E, Buster, Erik H.C.J, Steyerberg, Ewout W, Lesaffre, Emmanuel, Janssen, Harry L.A

Volltext

The importance of HBV genotype in HBeAg-positive chronic hepatitis B patients in whom sustained response is pursued von Buster, Erik H.C.J, Janssen, Harry L.A

Volltext

Comments on the EASL practice guidelines for the management of chronic hepatitis B: Controversies in interferon-based therapy von Janssen, Harry L.A, Buster, Erik H.C.J

Volltext

Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathiopr... von Buster, Erik H.C.J, van Vuuren, Hanneke J, Zondervan, Pieter E, Metselaar, Herold J, Tilanus, Hugo W, de Man, Robert A

Volltext

Implementation of a regional video multidisciplinary team meeting is associated with an improved prognosis for patients with oesophageal cancer A mixed methods approach von Luijten, Josianne C.H.B.M., Haagsman, Vera C., Luyer, Misha D.P., Vissers, Pauline A.J., Nederend, Joost, Huysentruyt, Clément, Creemers, Geert-Jan, Curvers, Wouter, van der Sangen, Maurice, Heesakkers, Fanny B.M., Schrauwen, Ruud W.M., Jürgens, Matthias C., Buster, Erik H.C.J., Vincent, Jeroen, Kneppelhout, Jan Kees, Verhoeven, Rob H.A., Nieuwenhuijzen, Grard A.P.

Volltext

Peginterferon alpha‐2b is safe and effective in HBeAg‐positive chronic hepatitis B patients with advanced fibrosis von Buster, Erik H. C. J., Hansen, Bettina E., Buti, Maria, Delwaide, Jean, Niederau, Claus, Michielsen, Peter P., Flisiak, Robert, Zondervan, Pieter E., Schalm, Solko W., Janssen, Harry L. A.

Volltext

Low incidence of retinopathy during peginterferon α-2b and lamivudine therapy for chronic hepatitis B von Buster, Erik H.C.J., ter Borg, Martijn J., Vingerling, Johannes R., Janssen, Harry L.A.

Volltext